Takeaways: The positive reimbursement recommendation strengthens Kisunla’s commercial prospects in Canada and represents a significant step toward broader access to disease-modifying Alzhe...
Browsing Tag: Early Symptomatic Alzheimer's Disease
Takeaways: The positive reimbursement recommendation strengthens Kisunla’s commercial prospects in Canada and represents a significant step toward broader access to disease-modifying Alzhe...